The pharmaceutical industry has been actively seeking the ideal treatment for hepatitis C for years: a treatment whose features would be an eradication of the virus from the body in 100% of cases.
Availability of the documents relating to the 2014 combined general shareholders' meeting.
Founded in 1921 by a cooperative of French university professors, PUF is a publishing house specialising in the publication of books, journals, university manuals, essays and monographs in the field of humanities and
In 2013, an innovative neurology is emerging which is overcoming all kinds of hurdles: genetics, biotechnology, medical imaging, neurosurgery, the pharmaceutical industry… fundamental and clinical research are uniting
In December 2013 the Critical Illness Defi nitions and Geographical Variations Working Party presented their paper, ‘Extending the Critical Path’ to the Staple Inn Actuarial Society.
Winner of the Actuarial Award in Asia, 2013
In 2013, an innovative neurology is emerging which is overcoming all kinds of hurdles: genetics, biotechnology, medical imaging, neurosurgery, the pharmaceutical industry… fundamental and clinical research are uniting
In 2013, an innovative neurology is emerging which is overcoming all kinds of hurdles: genetics, biotechnology, medical imaging, neurosurgery, the pharmaceutical industry… fundamental and clinical research are uniting
In 2013, an innovative neurology is emerging which is overcoming all kinds of hurdles: genetics, biotechnology, medical imaging, neurosurgery, the pharmaceutical industry… fundamental and clinical research are uniting
In 2013, an innovative neurology is emerging which is overcoming all kinds of hurdles: genetics, biotechnology, medical imaging, neurosurgery, the pharmaceutical industry… fundamental and clinical research are uniting
The shareholders of SCOR SE are hereby informed that the annual ordinary and extraordinary Shareholders’ Meeting will take place at 10:00 on Tuesday 6 May 2014 at the SCOR group’s headquarters.
SCOR Global Life, a subsidiary of SCOR SE, has entered into a VIF (Value of In-Force) monetization transaction with Mediterráneo Vida, a Spanish insurance company fully owned by Banco Sabadell.
